Literature DB >> 33664746

Alternative Pathway Involvement in Protoporphyria Patients Related to Sun Exposure.

Francesca Granata1, Lorena Duca1, Valentina Brancaleoni1, Silvia Fustinoni2,3, Giacomo De Luca1, Irene Motta1,4, Giovanna Graziadei1, Elena Di Pierro1.   

Abstract

The homeostasis of tissues in a chronic disease is an essential function of the alternative pathway (AP) of the complement system (CS). However, if not controlled, it may also be detrimental to healthy cells with a consequent aggravation of symptoms. The protoporphyria (PP) is a rare chronic disease that causes phototoxicity in visible light with local skin pain and general malaise. In order to establish if there is a systemic involvement of the CS during sun exposure, we designed a non-invasive method with a serum collection in winter and summer from 19 PP and 13 controls to detect the levels of CS protein: Properdin, Factor H (FH), and C5. Moreover, the global radiation data were collected from the regional agency of environmental protection (ARPA). The results show growing values for every protein in patients with PP, compared to control, in both seasons, in particular in summer compared to winter. To reinforce the evidence, we have estimated the personal exposure of patients based on the global radiation data. The main factors of the AP increased over the season, confirming the involvement of the AP in relation to light exposure. The systemic response could justify the general malaise of patients after long light exposure and can be exploited to elucidate new therapeutic approaches.
Copyright © 2021 Granata, Duca, Brancaleoni, Fustinoni, De Luca, Motta, Graziadei and Di Pierro.

Entities:  

Keywords:  UV detection; alternative pathway; complement system; global radiation; phototoxic reaction; protoporphyria

Mesh:

Substances:

Year:  2021        PMID: 33664746      PMCID: PMC7921788          DOI: 10.3389/fimmu.2021.615620

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  38 in total

1.  Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria.

Authors:  Manisha Balwani; Hetanshi Naik; Karl E Anderson; D Montgomery Bissell; Joseph Bloomer; Herbert L Bonkovsky; John D Phillips; Jessica R Overbey; Bruce Wang; Ashwani K Singal; Lawrence U Liu; Robert J Desnick
Journal:  JAMA Dermatol       Date:  2017-08-01       Impact factor: 10.282

Review 2.  Photodynamic therapy--aspects of pain management.

Authors:  Christine Fink; Alexander Enk; Patrick Gholam
Journal:  J Dtsch Dermatol Ges       Date:  2015-01       Impact factor: 5.584

3.  Targeting properdin in the treatment of atypical haemolytic uraemic syndrome: better than eculizumab?

Authors:  Kate Smith-Jackson; Kevin J Marchbank
Journal:  Ann Transl Med       Date:  2018-11

4.  [Erythropoietic protoporphyria. A rare differential diagnosis among photosensitive diseases].

Authors:  C Schiekofer; T Vogt; J Reichrath
Journal:  Hautarzt       Date:  2012-12       Impact factor: 0.751

5.  Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo.

Authors:  R H Pottier; Y F Chow; J P LaPlante; T G Truscott; J C Kennedy; L A Beiner
Journal:  Photochem Photobiol       Date:  1986-11       Impact factor: 3.421

Review 6.  New photosensitizers for photodynamic therapy.

Authors:  Heidi Abrahamse; Michael R Hamblin
Journal:  Biochem J       Date:  2016-02-15       Impact factor: 3.857

7.  Properdin-Mediated C5a Production Enhances Stable Binding of Platelets to Granulocytes in Human Whole Blood.

Authors:  Adam Z Blatt; Gurpanna Saggu; Koustubh V Kulkarni; Claudio Cortes; Joshua M Thurman; Daniel Ricklin; John D Lambris; Jesus G Valenzuela; Viviana P Ferreira
Journal:  J Immunol       Date:  2016-04-25       Impact factor: 5.422

8.  The alternative complement pathway is dysregulated in patients with chronic heart failure.

Authors:  Negar Shahini; Annika E Michelsen; Per H Nilsson; Karin Ekholt; Lars Gullestad; Kaspar Broch; Christen P Dahl; Pål Aukrust; Thor Ueland; Tom Eirik Mollnes; Arne Yndestad; Mieke C Louwe
Journal:  Sci Rep       Date:  2017-02-14       Impact factor: 4.379

Review 9.  Complement Activation in Inflammatory Skin Diseases.

Authors:  Jenny Giang; Marc A J Seelen; Martijn B A van Doorn; Robert Rissmann; Errol P Prens; Jeffrey Damman
Journal:  Front Immunol       Date:  2018-04-16       Impact factor: 7.561

10.  Evaluating quality of life tools in North American patients with erythropoietic protoporphyria and X-linked protoporphyria.

Authors:  Hetanshi Naik; Jessica R Overbey; Robert J Desnick; Karl E Anderson; D Montgomery Bissell; Joseph Bloomer; Herbert L Bonkovsky; John D Phillips; Bruce Wang; Ashwani Singal; Manisha Balwani
Journal:  JIMD Rep       Date:  2019-09-14
View more
  2 in total

Review 1.  Psychological Aspect and Quality of Life in Porphyrias: A Review.

Authors:  Granata Francesca; Annamaria Nicolli; Alessia Colaiocco; Elena Di Pierro; Giovanna Graziadei
Journal:  Diagnostics (Basel)       Date:  2022-05-10

Review 2.  Recognized and Emerging Features of Erythropoietic and X-Linked Protoporphyria.

Authors:  Elena Di Pierro; Francesca Granata; Michele De Canio; Mariateresa Rossi; Andrea Ricci; Matteo Marcacci; Giacomo De Luca; Luisa Sarno; Luca Barbieri; Paolo Ventura; Giovanna Graziadei
Journal:  Diagnostics (Basel)       Date:  2022-01-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.